Increased expression of activated endothelial nitric oxide synthase contributes to antiandrogen resistance in prostate cancer cells by suppressing androgen receptor transactivation
Authors:
- Shan YuSYShan Yu
- Lin JiaLJLin Jia
- Yan ZhangYZYan Zhang
- Dinglan WuDWDinglan Wu
- Zhenyu XuZXZhenyu Xu
- Chi-Fai NgCNChi-Fai Ng
- Kenneth K.W. ToKenneth K.W. To
- Yu HuangYu Huang
- Franky L. ChanFCFranky L. Chan
- 1 January 2013
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 328 (1) , 83-94
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Phase II Study of Nitric Oxide Donor for Men With Increasing Prostate-specific Antigen Level After Surgery or Radiotherapy for Prostate CancerUrology, 2009
- Endothelial NOS, estrogen receptor β, and HIFs cooperate in the activation of a prognostic transcriptional pattern in aggressive human prostate cancerJournal of Clinical Investigation, 2009
- Interleukin-6 increases prostate cancer cells resistance to bicalutamide via TIF2Molecular Cancer Therapeutics, 2009
- Nitric oxide synthase gene polymorphisms and prostate cancer riskCarcinogenesis, 2009
- The -786T>C promoter polymorphism of the NOS3gene is associated with prostate cancer progressionBMC Cancer, 2008
- The orphan receptor ERRα interferes with steroid signalingNucleic Acids Research, 2008
- Antiandrogens in the Treatment of Prostate CancerEuropean Urology, 2007
- Molecular determinants of resistance to antiandrogen therapyNature Medicine, 2003
- Androgen receptor gene amplification and protein expression in hormone refractory prostate cancerBritish Journal of Cancer, 2003
- The prognostic value of inducible nitric oxide synthase in local prostate cancerBJU International, 2000